Location History:
- Brookline, MA (US) (2000)
- Brighton, MA (US) (2021)
Company Filing History:
Years Active: 2000-2021
Title: Vladimir Gabai: Innovator in Pharmaceutical Safety and Inflammation Treatment
Introduction
Vladimir Gabai is a notable inventor based in Brighton, MA (US), recognized for his contributions to pharmaceutical safety and the treatment of inflammation-associated diseases. With a total of 3 patents, his work focuses on enhancing the safety and efficacy of various compositions, particularly quercetin.
Latest Patents
Gabai's latest patents include innovative methods for monitoring the safety of quercetin compositions. These methods aim to identify contaminants that may arise from the degradation of quercetin, especially when stored in air. The contaminants of concern include protocatechuic acid, 2,4,6-trihydroxybenzoic acid, and 2-(3,4-dihydroxybenzoyloxy)-4,6-dihydroxybenzoic acid. His research also provides methods to reduce the degradation of solid form quercetin compositions, thereby increasing their shelf life and ensuring patient safety.
Another significant patent involves methods and compositions related to p62/SQSTM1 for treating and preventing inflammation-associated diseases. Gabai's novel p62 compositions modulate the expression of proinflammatory cytokines and other factors, making them useful for the prophylaxis and treatment of various inflammatory diseases. These diseases include osteoporosis, obesity, type 2 diabetes, and neurodegenerative conditions, among others.
Career Highlights
Throughout his career, Gabai has worked with various organizations, contributing to advancements in pharmaceutical research. His experience includes significant roles in companies that focus on chemical and pharmaceutical innovations.
Collaborations
Gabai has collaborated with notable professionals in his field, including Michael Sherman and Alexander Shneider. These partnerships have likely enhanced the scope and impact of his research.
Conclusion
Vladimir Gabai's innovative work in the field of pharmaceutical safety and inflammation treatment highlights his commitment to improving health outcomes through scientific research. His patents reflect a deep understanding of the complexities involved in drug safety and efficacy.